IceCure Medical Ltd
ICCM
$0.30
$0.00-0.33%
NASDAQ
| 12/31/2025 | 06/30/2025 | 12/31/2024 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Net Income | 5.20% | -9.19% | -49.55% | -3.73% | |
| Total Depreciation and Amortization | -13.41% | -24.39% | -1.20% | 1.22% | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | -67.56% | -55.44% | 389.13% | -74.30% | |
| Change in Net Operating Assets | -3,886.96% | -8.58% | -111.92% | 336.20% | |
| Cash from Operations | -19.64% | -18.96% | -56.94% | -6.20% | |
| Capital Expenditure | 0.00% | -266.67% | 93.83% | 58.44% | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | 250,100.00% | 99.88% | -100.02% | -78.71% | |
| Cash from Investing | 71,457.14% | 97.27% | -100.08% | -79.11% | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | 203.59% | -95.50% | 2,235.29% | 22,293.33% | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -126.08% | -- | -- | -- | |
| Cash from Financing | 237.87% | 10.32% | 1,519.12% | 22,293.33% | |
| Foreign Exchange rate Adjustments | 3,933.33% | 4,500.00% | -102.63% | 107.62% | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | 226.36% | 50.00% | -146.32% | 28.18% | |